Dr Lazar speaks with ecancer at AACR 2017 about what the WIN symposium offers, how it compares to other oncology meetings taking place around the globe, and what innovations he foresees in cancer treatment.

He highlights the globally co-operative attitude of WIN consortium, reflected in the theme of this years conference, and introduces some key speakers.

Dr Lazar notes room for improvement in streamlining early diagnosis and delivering the latest therapies to clinics globally, and considers the future indications of combination therapies.

For more about the WIN consortium click here, or watch interviews from last year's symposium here.